AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Solifenacin Succinate in Nigeria
6 products registered with NAFDAC — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| GOAB 5 Tablets** Tablet | A4-100727 | Hetero Labs Nigeria Limited | active | 30 Jan 2029 |
| GOAB 10 Tablets** Tablet | A4-100712 | Hetero Labs Nigeria Limited | active | 30 Jan 2029 |
| Solifen 10 mg Tablet Tablet | B4-9700 | Getz Pharma Nigeria Limited | active | 20 Dec 2028 |
| Solifen Tablet 5 mg Tablet | B4-9699 | Getz Pharma Nigeria Limited | active | 20 Dec 2028 |
| Vesizen Tablets 5 mg Film coated tablet | B4-8259 | Ranbaxy Nigeria Limited | active | 30 Oct 2028 |
| Vesizen 10 mg Tablets Tablet | B4-8531 | Ranbaxy Nigeria Limited | active | 26 May 2026 |
Solifenacin Succinate — NAFDAC Registration Details
NAFDAC (Nigeria) has 6 registered products containing Solifenacin Succinate, of which 6 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Solifenacin Succinate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.